These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1908751)

  • 1. Alternating chemotherapy in advanced gastric cancer. A phase II study.
    Feliu J; Girón CG; González-Baron M; Berrocal A; Barón-Saura JM
    Cancer Chemother Pharmacol; 1991; 28(4):313-4. PubMed ID: 1908751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapy of advanced gastric carcinoma (stage IV): a randomized study of FAM versus 5-FU plus BCNU.
    Villar A; Asensio F; Candel M; Delgado F; Garcia J; Lledó S; Redón J; Roig JV; Sanchez A; Sanchis C
    Chemioterapia; 1987 Feb; 6(1):57-62. PubMed ID: 3103932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-Fluorouracil versus a combination of BCNU, adriamycin, 5-FU and mitomycin C in advanced gastric cancer: a prospective randomized study of the Italian Clinical Research Oncology Group.
    De Lisi V; Cocconi G; Tonato M; Di Costanzo F; Leonardi F; Soldani M
    Recent Results Cancer Res; 1988; 110():212-8. PubMed ID: 3136519
    [No Abstract]   [Full Text] [Related]  

  • 4. A phase III randomized study of 5-fluorouracil and cisplatin versus 5-fluorouracil, doxorubicin, and mitomycin C versus 5-fluorouracil alone in the treatment of advanced gastric cancer.
    Kim NK; Park YS; Heo DS; Suh C; Kim SY; Park KC; Kang YK; Shin DB; Kim HT; Kim HJ
    Cancer; 1993 Jun; 71(12):3813-8. PubMed ID: 8508349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The combination of cisplatin, doxorubicin, and mitomycin (PAM) compared with the FAM regimen in treating advanced gastric carcinoma. A phase II randomized trial of the Italian Oncology Group for Clinical Research.
    De Lisi V; Cocconi G; Angelini F; Cavicchi F; Di Costanzo F; Gilli G; Rodinò C; Soldani M; Tonato M; Finardi C
    Cancer; 1996 Jan; 77(2):245-50. PubMed ID: 8625230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous infusion 5-fluorouracil with bolus adriamycin and mitomycin and low-dose cisplatin (FAMP) in the treatment of metastatic gastric carcinoma: an evaluation of efficacy and toxicity.
    Raschko JW; Johnson EA; Ueno W; Woolley PV; Treat J
    Cancer Invest; 1991; 9(1):49-51. PubMed ID: 2012996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined cisplatin, doxorubicin, and mitomycin for the treatment of advanced pleural mesothelioma: a phase II FONICAP trial. Italian Lung Cancer Task Force.
    Pennucci MC; Ardizzoni A; Pronzato P; Fioretti M; Lanfranco C; Verna A; Giorgi G; Vigani A; Frola C; Rosso R
    Cancer; 1997 May; 79(10):1897-902. PubMed ID: 9149015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Combination chemotherapy of advanced gastric cancer with adriamycin, mitomycin C, and ftorafur].
    Miyamoto H; Ogawa M; Inagaki J; Horikoshi N; Ezaki K; Inoue K; Ikeda K; Usui N; Nakada H; Okada Y
    Gan To Kagaku Ryoho; 1983 Apr; 10(4 Pt 2):1160-4. PubMed ID: 6408998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-dose mitomycin and weekly low-dose doxorubicin combination chemotherapy for patients with metastatic breast carcinoma previously treated with cyclophosphamide, methotrexate, and 5-fluorouracil.
    Colozza M; Tonato M; Grignani F; Davis S
    Cancer; 1988 Jul; 62(2):262-5. PubMed ID: 3383126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advanced gastric carcinoma chemotherapy with cisplatin, mitomycin C, BCNU, and 5-fluorouracil in combination.
    Kim RH; Lee YW; Lee DC; Kim NH; Choi JS; Joo SK; Kim CS
    Korean J Intern Med; 1987 Jan; 2(1):48-51. PubMed ID: 3154817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feasibility study of combining metronidazole with chemotherapy.
    Stewart DJ; Maroun JA; Young V; Crook AF; Hopkins HS; Yan RC; Richard MT; Hugenholtz H; Bélanger R; Heringer R
    J Clin Oncol; 1983 Jan; 1(1):17-23. PubMed ID: 6422002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapy of advanced gastric carcinoma. The Georgetown-Lombardi Cancer Center experience.
    Treat J; Falchuk SC; Woolley PV; Ahlgren JD; Neefe JR; Smith FP; Macdonald JS; Schein PS
    Am J Clin Oncol; 1989 Apr; 12(2):162-8. PubMed ID: 2523188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction with mitomycin C, doxorubicin, cisplatin and maintenance with weekly 5-fluorouracil, leucovorin for treatment of metastatic nasopharyngeal carcinoma: a phase II study.
    Hong RL; Sheen TS; Ko JY; Hsu MM; Wang CC; Ting LL
    Br J Cancer; 1999 Aug; 80(12):1962-7. PubMed ID: 10471046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of PMU hepatic arterial chemotherapy for liver metastases of gastric cancer. Hokuriku Cisplatin Round-table Conference].
    Sakuma H; Matsuki N; Katayama K; Hirosawa H; Tomita F; Takano N; Tanaka T; Sawa T; Ueno K; Uogishi M
    Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 1):2557-62. PubMed ID: 2505681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Etoposide, doxorubicin and cisplatin (EAP regimen) in advanced gastric cancer.
    Scarpellini M; Tononi A; Pasquini E; Oliverio G; Fattori PP; Gianni L; Desiderio F; Nicolini M; Ravaioli A
    J Chemother; 1994 Jun; 6(3):211-5. PubMed ID: 7983505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitomycin, ifosfamide and cisplatin in advanced non-small cell lung cancer.
    Soh LT; Tan EH; Ang PT
    Singapore Med J; 1998 Aug; 39(8):357-8. PubMed ID: 9844496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II trial of etoposide, doxorubicin, and cisplatin combination in advanced measurable gastric cancer. An Eastern Cooperative Oncology Group study.
    Clark JL; Küçük O; Neuberg DS; Benson AB; Taylor SG; Pandya KJ; Mansour EG; Douglass HO; Haller DG
    Am J Clin Oncol; 1995 Aug; 18(4):318-24. PubMed ID: 7625373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Combination chemotherapy of 5-fluorouracil (5-FU), adriamycin (ADM), cis-diamminedichloroplatinum (II) (CDDP) and mitomycin C (MMC) (FAP.MMC) in advanced gastric cancer].
    Ozeki H; Ogawa M; Horikoshi N; Inoue K; Mukaiyama T; Nagamine D; Ito Y; Imajo K; Shinagawa K
    Gan To Kagaku Ryoho; 1988 Jan; 15(1):91-5. PubMed ID: 3122669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A cooperative randomized study on tegafur plus mitomycin C versus combined tegafur and uracil plus mitomycin C in the treatment of advanced gastric cancer.
    Kurihara M; Izumi T; Yoshida S; Ohkubo T; Suga S; Kiyohashi A; Yaosaka T; Takahashi H; Ito T; Sasai T
    Jpn J Cancer Res; 1991 May; 82(5):613-20. PubMed ID: 1905707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chemotherapy of stomach cancer].
    Gropp C; Havemann K
    Z Gastroenterol; 1982 Dec; 20(12):703-9. PubMed ID: 6819730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.